Heineken keeps eye on cost as earnings jump

Firm well-equipped to navigate challenges

Heineken 4Q21 net profit jumps 77% to RM95.8mil

KUALA LUMPUR: Heineken Malaysia Bhd, which posted a 77% jump in net profit to RM95.84mil in the fourth quarter ended Dec 31, 2021 (4Q21), has declared a single tier final dividend of 66 sen per share.

Pfizer vaccine for children under 5 may be available in US by end-Feb

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.

CanSino’s Covid-19 vaccine approved as booster shot

KUALA LUMPUR: Solution Group Bhd (SGB) has announced that the CanSino Biologics Inc’s single-dose Convidecia vaccine has obtained conditional approval as a booster shot from Malaysia’s Drug Control Authority (DCA), under the National Pharmaceutical Regulatory Agency (NPRA).

Malaysia’s outlook in 2022: Five risks to watch

TWO years into the Covid-19 pandemic, the Malaysian economy is now coming out of its trough after shrinking 4.5% in the third quarter of 2021. It is on a path to recovery in 2022, supported by the reopening of economic and social sectors.

Ringgit higher versus US dollar as Omicron fears recede

KUALA LUMPUR: The ringgit extended its uptrend on Friday as reduced Omicron fears helped boost risk appetite.

A healthy pick

Health sector remains an attractive bet, say equity analysts

KWAN allocation increased to RM6bil to ensure adequate vaccine supply: Tengku Zafrul

KUALA LUMPUR: The government has decided to increase the National Trust Fund (KWAN) allocation to RM6 billion from RM5 billion previously to ensure a sufficient supply of vaccines, including booster doses, for not only the adult population but also teenagers.

Oil prices plunge as Omicron's rapid spread dims fuel demand outlook

NEW YORK: Oil prices slumped on Monday as surging cases of the Omicron coronavirus variant in Europe and the United States stoked investor worries that new restrictions to combat its spread could dent fuel demand.